Cardiometabolic risk management in type 2 diabetes and obesity. - Wikidata - wikimedia - TriplyDB

Cardiometabolic risk management in type 2 diabetes and obesity.

Cardiometabolic risk management in type 2 diabetes and obesity.

http://www.wikidata.org/entity/Q30446865

about

A randomized clinical trial of diabetes self-management for Mexican Americans: Are there serendipitous health benefits for supporters of study participants?

P2860

Q37641252-951BD759-F666-463E-9BE0-17EA02EE3104

P2860

Cardiometabolic risk management in type 2 diabetes and obesity.

http://www.wikidata.org/entity/Q30446865

description

2008 nî lūn-bûn

@nan

2008 թուականի Հոկտեմբերին հրատարակուած գիտական յօդուած

@hyw

2008 թվականի հոտեմբերին հրատարակված գիտական հոդված

@hy

2008年の論文

@ja

2008年論文

@yue

2008年論文

@zh-hant

2008年論文

@zh-hk

2008年論文

@zh-mo

2008年論文

@zh-tw

2008年论文

@wuu

name

Cardiometabolic risk management in type 2 diabetes and obesity.

@ast

Cardiometabolic risk management in type 2 diabetes and obesity.

@en

type

label

Cardiometabolic risk management in type 2 diabetes and obesity.

@ast

Cardiometabolic risk management in type 2 diabetes and obesity.

@en

prefLabel

Cardiometabolic risk management in type 2 diabetes and obesity.

@ast

Cardiometabolic risk management in type 2 diabetes and obesity.

@en

P1433

Q30446865-10A4880B-C5DC-410E-84CB-2A9CD0C500E2

P1476

Q30446865-3F43A23C-F2F7-401B-9FEC-16D5ED58F55C

P2093

Q30446865-C36A424D-A8C8-4C16-89F0-D30279B3FE55

P2860

Q30446865-42B3FE7C-7798-4DF8-A2E3-79D070E20DEA

Q30446865-52252171-5BDE-47BB-A498-30C58A301717

Q30446865-A7454EEA-3731-4F45-AF13-DFD32BC06B5B

Q30446865-B4DE10F2-2D3B-47B9-ACDB-A4C9B51BD6EC

Q30446865-DFB477F0-5A5F-41A1-8741-174B50273850

P2888

Q30446865-A1BB7434-48D0-4059-9930-C03C7484CD7C

P304

Q30446865-B442C734-42F2-43E9-B396-A2A211E4B8BB

P31

Q30446865-514FE7CE-0643-4967-8E95-9D24358A4EA2

P356

Q30446865-9C581B86-67E8-43DC-BC11-C9BE201F137E

P433

Q30446865-4D791FD1-3480-4F3E-8840-A418C023D853

P478

Q30446865-0F3BD51B-9D7A-4EA3-B714-C0C558BC16C6

P577

Q30446865-E2B1FB3E-A30D-427B-BF4E-DF92FAB81ED8

P6179

Q30446865-F03743C5-1AAD-4E70-8550-9E64F8D24E76

P698

Q30446865-D552323B-AAE0-43C2-8ADF-724BBF3CD3FF

P921

Q30446865-78F646A7-2DA0-4D72-8C36-2BEBF6936126

Q30446865-A81366AD-AF66-4709-B487-CC77BEA1F4C8

P356

S11892-008-0061-7

P1433

Current diabetes report

P1476

Cardiometabolic risk management in type 2 diabetes and obesity.

@en

P2093

Angela M Taylor

http://www.w3.org/2001/XMLSchema#string

P2860

The evolving diabetes burden in the United States.

Predominance of dense low-density lipoprotein particles predicts angiographic benefit of therapy in the Stanford Coronary Risk Intervention Project.

Lipoproteins, apolipoproteins, and low-density lipoprotein size among diabetics in the Framingham offspring study.

Effect of diabetes on lipoprotein size.

Cardiovascular events and their reduction with pravastatin in diabetic and glucose-intolerant myocardial infarction survivors with average cholesterol levels: subgroup analyses in the cholesterol and recurrent events (CARE) trial. The Care Investiga

P2888

s11892-008-0061-7

P304

345-352

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1007/S11892-008-0061-7

http://www.w3.org/2001/XMLSchema#string

P433

5

http://www.w3.org/2001/XMLSchema#string

P478

8

http://www.w3.org/2001/XMLSchema#string

P577

2008-10-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P6179

1022886999

http://www.w3.org/2001/XMLSchema#string

P698

18778582

http://www.w3.org/2001/XMLSchema#string

P921

type-2 diabetes